Document is current
Any future updates will be listed below
-
Authors
Hasanpourghadi, Mohadeseh
Novikov, Mikhail
Newman, Dakota
Xiang, ZhiQuan
Zhou, Xiang Yang
Magowan, Colin
Ertl, Hildegund C. J. https://orcid.org/0000-0001-9795-5206
-
Funding
Funding for this research was provided by:
Virion Therapeutics
- License Information
-
More Information
Article History
Received: 28 March 2021
Accepted: 26 November 2021
First Online: 7 December 2021
Declarations
:
: The animal experiments in this study were approved by the Wistar’s Institutional Animal Care and Use Committee.
: Not applicable.
: Hildegund CJ Ertl is a co-founder and holds equity in Virion Therapeutics and has research sponsored by Virion Therapeutics. Colin Magowan owns equity in Virion Therapeutics and is an inventor on a patent application covering, in part, the material in this paper.
